These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Magnolol suppresses vascular endothelial growth factor-induced angiogenesis by inhibiting Ras-dependent mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt signaling pathways. Kim KM; Kim NS; Kim J; Park JS; Yi JM; Lee J; Bang OS Nutr Cancer; 2013; 65(8):1245-53. PubMed ID: 24066970 [TBL] [Abstract][Full Text] [Related]
4. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways. Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629 [TBL] [Abstract][Full Text] [Related]
5. Liquiritigenin inhibits serum-induced HIF-1α and VEGF expression via the AKT/mTOR-p70S6K signalling pathway in HeLa cells. Xie SR; Wang Y; Liu CW; Luo K; Cai YQ Phytother Res; 2012 Aug; 26(8):1133-41. PubMed ID: 22170854 [TBL] [Abstract][Full Text] [Related]
6. 4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells. Gao N; Nester RA; Sarkar MA Toxicol Appl Pharmacol; 2004 Apr; 196(1):124-35. PubMed ID: 15050414 [TBL] [Abstract][Full Text] [Related]
7. Ascofuranone suppresses EGF-induced HIF-1α protein synthesis by inhibition of the Akt/mTOR/p70S6K pathway in MDA-MB-231 breast cancer cells. Jeong YJ; Cho HJ; Magae J; Lee IK; Park KG; Chang YC Toxicol Appl Pharmacol; 2013 Dec; 273(3):542-50. PubMed ID: 24096035 [TBL] [Abstract][Full Text] [Related]
8. Magnolol inhibits angiogenesis by regulating ROS-mediated apoptosis and the PI3K/AKT/mTOR signaling pathway in mES/EB-derived endothelial-like cells. Kim GD; Oh J; Park HJ; Bae K; Lee SK Int J Oncol; 2013 Aug; 43(2):600-10. PubMed ID: 23708970 [TBL] [Abstract][Full Text] [Related]
9. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804 [TBL] [Abstract][Full Text] [Related]
10. Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia. Chen MC; Hsu WL; Hwang PA; Chou TC Mar Drugs; 2015 Jul; 13(7):4436-51. PubMed ID: 26193287 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling. Huang SW; Lien JC; Kuo SC; Huang TF Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611 [TBL] [Abstract][Full Text] [Related]
12. GABARBP down-regulates HIF-1α expression through the VEGFR-2 and PI3K/mTOR/4E-BP1 pathways. Park SH; Kim BR; Lee JH; Park ST; Lee SH; Dong SM; Rho SB Cell Signal; 2014 Jul; 26(7):1506-13. PubMed ID: 24686084 [TBL] [Abstract][Full Text] [Related]
13. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Cao Z; Fang J; Xia C; Shi X; Jiang BH Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429 [TBL] [Abstract][Full Text] [Related]
14. IPD-196, a novel phosphatidylinositol 3-kinase inhibitor with potent anticancer activity against hepatocellular carcinoma. Lee JH; Lee H; Yun SM; Jung KH; Jeong Y; Yan HH; Hong S; Hong SS Cancer Lett; 2013 Feb; 329(1):99-108. PubMed ID: 23142281 [TBL] [Abstract][Full Text] [Related]
15. (-)-Epigallocatechin-3-gallate inhibits human papillomavirus (HPV)-16 oncoprotein-induced angiogenesis in non-small cell lung cancer cells by targeting HIF-1α. He L; Zhang E; Shi J; Li X; Zhou K; Zhang Q; Le AD; Tang X Cancer Chemother Pharmacol; 2013 Mar; 71(3):713-25. PubMed ID: 23292117 [TBL] [Abstract][Full Text] [Related]
16. Effects of YC-1 on hypoxia-inducible factor 1 alpha in hypoxic human bladder transitional carcinoma cell line T24 cells. Li Y; Zhao X; Tang H; Zhong Z; Zhang L; Xu R; Li S; Wang Y Urol Int; 2012; 88(1):95-101. PubMed ID: 22041818 [TBL] [Abstract][Full Text] [Related]
17. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis. Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542 [TBL] [Abstract][Full Text] [Related]
18. A novel imidazopyridine derivative, HS-106, induces apoptosis of breast cancer cells and represses angiogenesis by targeting the PI3K/mTOR pathway. Li GY; Jung KH; Lee H; Son MK; Seo J; Hong SW; Jeong Y; Hong S; Hong SS Cancer Lett; 2013 Feb; 329(1):59-67. PubMed ID: 23085493 [TBL] [Abstract][Full Text] [Related]
19. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway. Jung KH; Choi MJ; Hong S; Lee H; Hong SW; Zheng HM; Lee HS; Hong S; Hong SS Cancer Lett; 2012 Mar; 316(2):187-95. PubMed ID: 22182943 [TBL] [Abstract][Full Text] [Related]
20. Apigenin inhibits expression of vascular endothelial growth factor and angiogenesis in human lung cancer cells: implication of chemoprevention of lung cancer. Liu LZ; Fang J; Zhou Q; Hu X; Shi X; Jiang BH Mol Pharmacol; 2005 Sep; 68(3):635-43. PubMed ID: 15947208 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]